Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 12, 2005, Pages 1131-1136

  Koike, Marcia Kiyomi ^a   De Carvalho Frimm, Clovis ^a   De Lourdes Higuchi, Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bradykinin; Fibrosis; Inflammation; Mast cells; Myocardial infarction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BRADYKININ B2 RECEPTOR ANTAGONIST; COLLAGEN; DYE; EOSIN; HEMATOXYLIN; ICATIBANT; PICROSIRIUS RED; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ACTIN; BRADYKININ; BRADYKININ B2 RECEPTOR; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GIEMSA STAIN; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE SEPTUM; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LEFT CORONARY ARTERY; MALE; MAST CELL; MORPHOMETRICS; MYOCARDITIS; NONHUMAN; RAT; TISSUE SECTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; FIBROSIS; HEART MUSCLE; HEART VENTRICLE; INFLAMMATION; METABOLISM; PATHOLOGY; WISTAR RAT; WOUND HEALING;

ACTINS; ANIMALS; BRADYKININ; COLLAGEN; FIBROSIS; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MAST CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; WOUND HEALING;

EID: 33644972444     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04309.x     Document Type: Article

References (37)

1. de Carvalho Frimm C Sun Y Weber K. Wound healing following MI in the rat: Role for bradykinin and prostaglandins. J. Mol. Cell Cardiol. 1996 28 : 1279 85.
2. Douillet CD Velarde V Christopher JT Mayfield RK Trojanowska ME Jaffa AA. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: Role of TGF-beta and MAPK. Am. J. Physiol. Heart Circ. Physiol. 2000 279 : H2829 37.
3. Goldstein RH Wall M. Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin. J. Biol. Chem. 1984 259 : 9263 8.
4. Kim NN Villegas S Summerour SR Villarreal FJ. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J. Mol. Cell. Cardiol. 1999 31 : 457 66.
5. Souza DG Lomez ES Pinho V et al. Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J. Immunol. 2004 172 : 2542 8.
6. Shigematsu S Ishida S Gute DC Korthuis RJ. Bradykinin-induced proinflammatory signaling mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2002 283 : H2676 86.
7. Wei CC Lucchesi PA Tallaj J Bradley WE Powell PC Dell'Italia LJ. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am. J. Physiol. Heart Circ. Physiol. 2003 285 : H784 92.
8. Heitsch H. Bradykinin B2 receptor as a potential therapeutic target. Drug News Perspect. 2000 13 : 213 25.
9. Gavras I Gavras H. Metabolic effects of angiotensin-converting enzyme inhibition: The role of bradykinin. Curr. Opin. Endocrinol. Diabetes 2002 9 : 323 8.
10. Sun Y Diaz-Arias AA Weber KT. Angiotensin-converting enzyme, bradykinin, and angiotensin II receptor binding in rat skin, tendon, and heart valves: An in vitro, quantitative autoradiographic study. J. Lab. Clin. Med. 1994 123 : 372 7.
11. Sun Y Ratajska A Weber K. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: Response to chronic angiotensin II or aldosterone administration in rats. J. Mol. Cell. Cardiol. 1995 27 : 813 22.
12. Sun Y Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 1994 28 : 1623 8.
13. Hebda PA Collins MA Tharp MD. Mast cell and myofibroblast in wound healing. Dermatol. Clin. 1993 11 : 685 96.
14. Gailit J Marchese MJ Kew RR Gruber BL. The differentiation and function of myofibroblasts is regulated by mast cell mediators. J. Invest. Dermatol. 2001 117 : 1113 19.
15. de Carvalho Frimm C Koike MK Cúri M. Subendocardial fibrosis in remote myocardium is associated with reduction of coronary driving pressure during acute infarction in rats. Arq. Bras. Cardiol. 2003 80 : 515 20.
16. Sun Y Zhang J Lu L Bedigian MP Robinson AD Weber KT. Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. J. Lab. Clin. Med. 2004 143 : 41 51.
17. Boyle MP Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 1993 88 : 2872 83.
18. Kirsner RS Eaglstein WH. The wound healing process. Dermatol. Clin. 1993 11 : 629 40.
19. Santos DR Calixto JB Souza GE. Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. Br. J. Pharmacol. 2003 139 : 271 8.
20. Hill GS Delahousse M Nochy D et al. Outcome of relapse in lupus nephritis: Roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 2002 61 : 2176 86.
21. Fonseca JE Canhao H Resende C et al. Histology of the synovial tissue: Value of semiquantitative analysis for the prediction of joint erosions in rheumatoid arthritis. Clin. Exp. Rheumatol. 2000 18 : 559 64.
22. Ruzek MC Jha S Ledbetter S Richards SM Garman RD. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum. 2004 50 : 1319 31.
23. Luzina IG Atamas SP Wise R et al. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum. 2003 48 : 2262 74.
24. van den Berg A Jansen PL. Pathogenesis and medical therapy of primary sclerosing cholangitis. Any news? Eur. J. Gastroenterol. Hepatol. 1999 11 : 121 4.
25. Haraoui B Pelletier JP Cloutier JM Faure MP Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991 34 : 153 63.
26. Lindstedt KA Wang Y Shiota N et al. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function for chymase. FASEB J. 2001 15 : 1377 88.
27. Koskinen PK Kovanen PT Lindstedt KA Lemstrom KB. Mast cells in acute and chronic rejection of rat cardiac allografts: A major source of basic fibroblast growth factor. Transplantation 2001 71 : 1741 7.
28. Wollert KC Studer R Doerfer K et al. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation 1997 95 : 1910 17.
29. Brown Jr EJ Kloner RA Schoen FJ Hammerman H Hale S Braunwald E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am. J. Cardiol. 1983 51 : 877 83.
30. Hammerman H Kloner RA Schoen FJ Brown Jr EJ Hale S Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983 67 : 1290 5.
31. Hammerman H Schoen FJ Braunwald E Kloner RA. Drug-induced expansion of infarct: Morphologic and functional correlations. Circulation 1984 69 : 611 17.
32. Ito H Hayashi I Izumi T Majima M. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br. J. Pharmacol. 2003 138 : 225 33.
33. Shiota N Rysa J Kovanen PT Ruskoaho H Kokkonen JO Lindstedt KA. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J. Hypertens. 2003 21 : 1935 44.
34. Matsumoto T Wada A Tsutamoto T Ohnishi M Isono T Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 2003 107 : 2555 8.
35. Tsuda T Gao E Evangelisti L Markova D Ma X Chu M. Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc. Res. 2003 59 : 926 33.
36. Stewart Jr JA Wei CC Brower GL et al. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J. Mol. Cell. Cardiol. 2003 35 : 311 19.
37. Chancey AL Brower GL Janicki JS. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am. J. Physiol. Heart Circ. Physiol. 2002 282 : H2152 8.